Mckesson (MCK) Total Non-Current Liabilities (2009 - 2026)
Mckesson's (MCK) quarterly Total Non-Current Liabilities came in at -$2.4 billion in Q1 2026, up 57.29% year-on-year from -$1.5 billion in Q1 2025, and down 102.91% on a QoQ basis from $81.4 billion in Q4 2025.
Mckesson (MCK) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 17 years of Total Non-Current Liabilities data on file, last reported at -$2.4 billion in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 57.29% year-over-year to -$2.4 billion in Q1 2026; TTM through Mar 2026 was -$2.4 billion, a 57.29% increase from a year earlier, with the FY2026 full-year figure at -$2.4 billion, up 57.29% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at -$2.4 billion, down from $81.4 billion in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for MCK reached as high as $81.4 billion in Q4 2025 and fell as low as -$6.1 billion in Q1 2024.
- Historically, Total Non-Current Liabilities has averaged $48.8 billion across 5 years, with a median of $60.2 billion in 2023.
- Across the five-year window, Total Non-Current Liabilities plunged 245.0% in 2024 and soared 57.29% in 2026, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $56.0 billion in 2022, then increased by 7.74% to $60.4 billion in 2023, then advanced by 13.4% to $68.5 billion in 2024, then advanced by 18.94% to $81.4 billion in 2025, then slumped by 102.91% to -$2.4 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were -$2.4 billion in Q1 2026, $81.4 billion in Q4 2025, and $81.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -2.37 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | -3.11 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | - |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 6.05 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | 2,565.00 |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 279.68 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 2.79 Bn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 58.52 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 40.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.37 Bn |
| Dec 31, 2025 | 81.45 Bn |
| Sep 30, 2025 | 81.41 Bn |
| Jun 30, 2025 | 78.44 Bn |
| Mar 31, 2025 | -5.55 Bn |
| Dec 31, 2024 | 68.48 Bn |
| Sep 30, 2024 | 69.72 Bn |
| Jun 30, 2024 | 65.56 Bn |
| Mar 31, 2024 | -6.07 Bn |
| Dec 31, 2023 | 60.38 Bn |
| Sep 30, 2023 | 59.96 Bn |
| Jun 30, 2023 | 57.47 Bn |
| Mar 31, 2023 | -1.76 Bn |
| Dec 31, 2022 | 56.05 Bn |
| Sep 30, 2022 | 56.44 Bn |
| Jun 30, 2022 | 60.74 Bn |
| Dec 31, 2021 | 56.56 Bn |
| Sep 30, 2021 | 62.04 Bn |
| Jun 30, 2021 | 55.30 Bn |
| Dec 31, 2020 | 60.00 Bn |